U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Unresectable Rhabdomyosarcoma

MedGen UID:
1649157
•Concept ID:
C4726599
•
Neoplastic Process

Definition

Rhabdomyosarcoma which is not amenable to surgical resection. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVUnresectable Rhabdomyosarcoma

Professional guidelines

PubMed

Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT
J Clin Oncol 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. PMID: 1985166

Recent clinical studies

Etiology

A prospective evaluation of the combined helical tomotherapy and chemotherapy in pediatric patients with unresectable rhabdomyosarcoma of the temporal bone.
Zhang X, Ma K, Wang J, Wu W, Ma L, Huang D
Cell Biochem Biophys 2014 Sep;70(1):103-8. doi: 10.1007/s12013-014-9864-0. PMID: 24619819
A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
Regine WF, Fontanesi J, Kumar P, Zeitzer K, Greenwald C, Bowman L, Shapiro DN, Rao BN, Kun LE
Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):799-805. doi: 10.1016/0360-3016(94)00459-5. PMID: 7860391
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN
Cancer 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. PMID: 8443761
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT
J Clin Oncol 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. PMID: 1985166
The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma.
Etcubanas E, Rao BN, Kun LE, Horowitz ME, Parham DM, Hustu HO, Green AA
Arch Surg 1987 Dec;122(12):1451-4. doi: 10.1001/archsurg.1987.01400240099018. PMID: 3689122

Diagnosis

Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP
Ann Surg Oncol 1996 Nov;3(6):521-5. doi: 10.1007/BF02306083. PMID: 8915482
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN
Cancer 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. PMID: 8443761

Therapy

A prospective evaluation of the combined helical tomotherapy and chemotherapy in pediatric patients with unresectable rhabdomyosarcoma of the temporal bone.
Zhang X, Ma K, Wang J, Wu W, Ma L, Huang D
Cell Biochem Biophys 2014 Sep;70(1):103-8. doi: 10.1007/s12013-014-9864-0. PMID: 24619819
Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP
Ann Surg Oncol 1996 Nov;3(6):521-5. doi: 10.1007/BF02306083. PMID: 8915482
A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
Regine WF, Fontanesi J, Kumar P, Zeitzer K, Greenwald C, Bowman L, Shapiro DN, Rao BN, Kun LE
Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):799-805. doi: 10.1016/0360-3016(94)00459-5. PMID: 7860391
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN
Cancer 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. PMID: 8443761
The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma.
Etcubanas E, Rao BN, Kun LE, Horowitz ME, Parham DM, Hustu HO, Green AA
Arch Surg 1987 Dec;122(12):1451-4. doi: 10.1001/archsurg.1987.01400240099018. PMID: 3689122

Prognosis

Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP
Ann Surg Oncol 1996 Nov;3(6):521-5. doi: 10.1007/BF02306083. PMID: 8915482
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN
Cancer 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. PMID: 8443761
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT
J Clin Oncol 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. PMID: 1985166
The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
Treuner J, Suder J, Keim M, Kaatsch P, Niethammer D
Acta Oncol 1989;28(1):67-72. doi: 10.3109/02841868909111184. PMID: 2706134

Clinical prediction guides

Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP
Ann Surg Oncol 1996 Nov;3(6):521-5. doi: 10.1007/BF02306083. PMID: 8915482
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.
Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN
Cancer 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. PMID: 8443761
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT
J Clin Oncol 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. PMID: 1985166
The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
Treuner J, Suder J, Keim M, Kaatsch P, Niethammer D
Acta Oncol 1989;28(1):67-72. doi: 10.3109/02841868909111184. PMID: 2706134

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...